noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

The eRulemaking Program

Relative Survival Rates by Time Since Diagnosis, 2000-2019 by Age,[...]
The eRulemaking Program

People Alive with Liver Cancer (U.S. Prevalence) on January 1, 2020 by[...]
The eRulemaking Program

People Alive with Liver Cancer (U.S. Prevalence) on January 1, 2020 by[...]

Equillium Inc.

07/12/2021 | Press release | Distributed by Public on 07/12/2021 14:02

Equillium Announces Plans to Initiate Phase 3 Pivotal Study of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease Following End-of-Phase 1 Meeting with the FDA

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Equillium Inc. | News | Health | Biotechnology | Healthcare Policy | Biotechnology | Science | Biotechnology | Research | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Book Publishing | Media and Publishing | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago

Back

Download the original document